BiotechTube

Berinert® (C1 Esterase Inhibitor)

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Includes: Hereditary Angioedema

Conditions

Includes: Hereditary Angioedema

Trial Timeline

Apr 1, 2010 → Apr 1, 2014

NCT ID
NCT01108848

About Berinert® (C1 Esterase Inhibitor)

Berinert® (C1 Esterase Inhibitor) is a pre-clinical stage product being developed by CSL for Includes: Hereditary Angioedema. The current trial status is completed. This product is registered under clinical trial identifier NCT01108848. Target conditions include Includes: Hereditary Angioedema.

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01108848Pre-clinicalCompleted